Efficacy and Safety of the New Intravenous Immunoglobulin IGIV 10% in Adults with Chronic Idiopathic Thrombocytopenic Purpura

Publisher： Karger

E-ISSN： 1660-3818|33|6|509-514

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.33, Iss.6, 2006-10, pp. : 509-514

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Randomized Trial of Anti-D Immunoglobulin versus Low-Dose Intravenous Immunoglobulin in the Treatment of Childhood Chronic Idiopathic Thrombocytopenic Purpura

By  

Acta Haematologica, Vol. 115, Iss. 1-2, 2006-01 ,pp. : 46-52

Karger

Access to resources Recommend Favorite

Autoantibody Level Modification in Adult Patients with Idiopathic Thrombocytopenic Purpura following Intravenous Immunoglobulin Treatment

By  

Natural Immunity, Vol. 16, Iss. 5-6, 2000-09 ,pp. : 207-214

Karger

Access to resources Recommend Favorite

Efficacy of Intravenous Immunoglobulin in the Treatment of Thrombotic Thrombocytopaenic Purpura

By  

Acta Haematologica, Vol. 105, Iss. 4, 2001-08 ,pp. : 204-208

Karger

Access to resources Recommend Favorite

Intravenous immunoglobulin as salvage therapy for refractory thrombotic thrombocytopenic purpura

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 3, 2018-03 ,pp. : E77-E79

John Wiley & Sons Inc

Access to resources Recommend Favorite

Use of romiplostim in patients with chronic idiopathic thrombocytopenic purpura during perioperative period

By  

INTERNAL MEDICINE JOURNAL, Vol. 45, Iss. 7, 2015-07 ,pp. : 718-724

John Wiley & Sons Inc

Access to resources Recommend Favorite